CLINICAL TRIALS PROFILE FOR UROCIT-K
✉ Email this page to a colleague
505(b)(2) Clinical Trials for UROCIT-K
Trial Type | Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|---|
OTC | NCT04651088 ↗ | Comparing Alkalinizing Agents Efficacy on Stone Risk in Patients on a Metabolically Controlled Diet | Not yet recruiting | University of Texas Southwestern Medical Center | Early Phase 1 | 2021-12-01 | The purpose of this study is to compare over the counter and alternative prescription urinary alkalinizing agents to slow release potassium citrate in their ability to modify urinary parameters associated with stone formation. |
>Trial Type | >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
All Clinical Trials for UROCIT-K
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT04651088 ↗ | Comparing Alkalinizing Agents Efficacy on Stone Risk in Patients on a Metabolically Controlled Diet | Not yet recruiting | University of Texas Southwestern Medical Center | Early Phase 1 | 2021-12-01 | The purpose of this study is to compare over the counter and alternative prescription urinary alkalinizing agents to slow release potassium citrate in their ability to modify urinary parameters associated with stone formation. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for UROCIT-K
Condition Name
Clinical Trial Progress for UROCIT-K
Clinical Trial Phase
Clinical Trial Sponsors for UROCIT-K
Sponsor Name